MedTrace Logo

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

NCT00625625 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2013-09-17

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as lymph node mapping during surgery and sentinel lymph node biopsy, may help doctors find micrometastases and predict cancer recurrence.

PURPOSE: This phase II trial is studying how well lymph node mapping during surgery together with sentinel lymph node analysis and blood testing work in detecting and predicting early micrometastases in patients with colorectal cancer.

Conditions

Interventions

DRUG

isosulfan blue

GENETIC

polymerase chain reaction

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

PROCEDURE

diagnostic lymphadenectomy

PROCEDURE

therapeutic conventional surgery

PROCEDURE

therapeutic lymphadenectomy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Saint John's Cancer Institute

    lead OTHER

Principal Investigators

  • Shamim Baker · Saint John's Cancer Institute

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00625625 on ClinicalTrials.gov